Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wilko Weichert

Showing results (311-320 of 504) with videos related to

Pageof 51
Sort By:
Cancers|December 24, 2021
Loss of SATB2 Occurs More Frequently Than CDX2 Loss in Colorectal Carcinoma and Identifies Particularly Aggressive Cancers in High-Risk SubgroupsMaxime Schmitt, Miguel Silva, Björn Konukiewitz, et al.
Human Pathology|September 28, 2010
Down-regulation of the antigen processing machinery is linked to a loss of inflammatory response in colorectal cancerAtsuko Kasajima, Christine Sers, Hironobu Sasano, et al.
Neoplasia (New York, N.Y.)|January 25, 2025
The chemokine CX3CL1 promotes intraperitoneal tumour growth despite enhanced T-cell recruitment in ovarian cancerStefanie Seitz, Tobias F Dreyer, Christoph Stange, et al.
Cancers|December 11, 2022
Correlation of Transcriptomics and FDG-PET SUVmax Indicates Reciprocal Expression of Stemness-Related Transcription Factor and Neuropeptide Signaling Pathways in Glucose Metabolism of Ewing SarcomaCarolin Prexler, Marie Sophie Knape, Janina Erlewein-Schweizer, et al.
European Journal of Cancer (Oxford, England : 1990)|February 27, 2023
Comprehensive biomarker analysis of long-term response to trastuzumab in patients with HER2-positive advanced gastric or gastroesophageal adenocarcinomaIsabel Porth, Daniela Hirsch, Yonca Ceribas, et al.
Annals of Surgery|July 11, 2017
R0 Versus R1 Resection Matters after Pancreaticoduodenectomy, and Less after Distal or Total Pancreatectomy for Pancreatic CancerIhsan Ekin Demir, Carsten Jäger, A Melissa Schlitter, et al.
Oncotarget|June 29, 2017
Increased intraepithelial CD3+ T-lymphocytes and high PD-L1 expression on tumor cells are associated with a favorable prognosis in esophageal squamous cell carcinoma and allow prognostic immunogenic subgroupingMoritz Jesinghaus, Katja Steiger, Julia Slotta-Huspenina, et al.
Oncotarget|April 23, 2016
Genetic changes of non-small cell lung cancer under neoadjuvant therapyArne Warth, Volker Endris, Albrecht Stenzinger, et al.
Breast Care (Basel, Switzerland)|February 26, 2019
Clinical Validation of <i>PITX2</i> DNA Methylation to Predict Outcome in High-Risk Breast Cancer Patients Treated with Anthracycline-Based ChemotherapyManfred Schmitt, Olaf G Wilhelm, Aurelia Noske, et al.
Oncotarget|September 18, 2014
Co-expression of MET and CD47 is a novel prognosticator for survival of luminal breast cancer patientsIrène Baccelli, Albrecht Stenzinger, Vanessa Vogel, et al.
Pageof 51

Showing results (311-320 of 504) with videos related to

Sort By:
Pageof 51
Cancers|December 24, 2021
Loss of SATB2 Occurs More Frequently Than CDX2 Loss in Colorectal Carcinoma and Identifies Particularly Aggressive Cancers in High-Risk SubgroupsMaxime Schmitt, Miguel Silva, Björn Konukiewitz, et al.
Human Pathology|September 28, 2010
Down-regulation of the antigen processing machinery is linked to a loss of inflammatory response in colorectal cancerAtsuko Kasajima, Christine Sers, Hironobu Sasano, et al.
Neoplasia (New York, N.Y.)|January 25, 2025
The chemokine CX3CL1 promotes intraperitoneal tumour growth despite enhanced T-cell recruitment in ovarian cancerStefanie Seitz, Tobias F Dreyer, Christoph Stange, et al.
Cancers|December 11, 2022
Correlation of Transcriptomics and FDG-PET SUVmax Indicates Reciprocal Expression of Stemness-Related Transcription Factor and Neuropeptide Signaling Pathways in Glucose Metabolism of Ewing SarcomaCarolin Prexler, Marie Sophie Knape, Janina Erlewein-Schweizer, et al.
European Journal of Cancer (Oxford, England : 1990)|February 27, 2023
Comprehensive biomarker analysis of long-term response to trastuzumab in patients with HER2-positive advanced gastric or gastroesophageal adenocarcinomaIsabel Porth, Daniela Hirsch, Yonca Ceribas, et al.
Annals of Surgery|July 11, 2017
R0 Versus R1 Resection Matters after Pancreaticoduodenectomy, and Less after Distal or Total Pancreatectomy for Pancreatic CancerIhsan Ekin Demir, Carsten Jäger, A Melissa Schlitter, et al.
Oncotarget|June 29, 2017
Increased intraepithelial CD3+ T-lymphocytes and high PD-L1 expression on tumor cells are associated with a favorable prognosis in esophageal squamous cell carcinoma and allow prognostic immunogenic subgroupingMoritz Jesinghaus, Katja Steiger, Julia Slotta-Huspenina, et al.
Oncotarget|April 23, 2016
Genetic changes of non-small cell lung cancer under neoadjuvant therapyArne Warth, Volker Endris, Albrecht Stenzinger, et al.
Breast Care (Basel, Switzerland)|February 26, 2019
Clinical Validation of <i>PITX2</i> DNA Methylation to Predict Outcome in High-Risk Breast Cancer Patients Treated with Anthracycline-Based ChemotherapyManfred Schmitt, Olaf G Wilhelm, Aurelia Noske, et al.
Oncotarget|September 18, 2014
Co-expression of MET and CD47 is a novel prognosticator for survival of luminal breast cancer patientsIrène Baccelli, Albrecht Stenzinger, Vanessa Vogel, et al.
Pageof 51